Pharma Co. Impel's Ch. 11 Liquidation Plan Approved

By Ben Zigterman · April 1, 2024, 5:07 PM EDT

Migraine-drug maker Impel Pharmaceuticals received confirmation of its Chapter 11 liquidation plan on Monday after selling its assets and making changes to the plan's exculpation provisions in response to a U.S....

To view the full article, register now.